Definitive Contract W81XWH17C0189

Award Date 9/25/17
Potential Completion Date 2/24/20
Potential Value $1M
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
San Diego, CA 92111, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
27
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,000,000.00 Phase II SBIR contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the rapid screening of individual cells using single cell mass spectrometry, supporting the NCI's biomedical research and development efforts. Nanocomposix has previously supported other federal agencies such as the Department of Defense...
<p>This is a $750,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Air Force Materiel Command to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, for the development of passive nanoparticle coatings. Nanocomposix has previously provided products and services to other federal agencies such as the Department of Health and Human Services and the Department of Defense. This contract is set aside for small businesses.</p>
The Department of the Army Materiel Command Research Development and Engineering Command awarded a $167,500.00 Firm Fixed Price contract to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, to develop drying processes for producing high aspect ratio conductive flakes using physical vapor deposition. This Small Business Innovation Research (SBIR) Program Phase I action contract was awarded on May 19, 2020, with a completion date of March 19, 2021. Nanocomposix has...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Nanocomposix, Inc. The $200,000.00 fixed-price contract is for the development of &quot;Surface Enhanced Fluorescence Nanotags for Ultrasensitive Multiplexed Assay Systems.&quot; As a small business manufacturer of engineered nanoparticles, Nanocomposix has previously received prime federal contracts and...
This is a $150,000.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a period of performance ending on March 30, 2016. Nanocomposix has provided similar products and services to the Department of Health and Human Services and Department of Defense in the past, including lateral flow assay devices, gold nanoparticles, and research and development for...
This is a Phase I Small Business Technology Transfer (STTR) contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Nanocomposix, Inc., a for-profit manufacturer of engineered nanoparticles. The $150,000.00 firm fixed price contract was awarded on June 23, 2017 with a completion date of March 31, 2018. Nanocomposix has previously received prime federal contracts from agencies such as the Department of Health and Human Services and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...
This firm fixed price purchase order contract, awarded by the Centers for Disease Control and Prevention (CDC) to Nanocomposix, Inc., is for $150,000.00 and is for research and development under the Small Business Innovation Research (SBIR) program. The contract is not set aside for a specific business type. Nanocomposix is a small business that manufactures engineered nanoparticles and has previously performed prime contracts and subcontractor work for the National Institutes of Health, Food...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Air Force Materiel Command to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the development of passive nanoparticle coatings with high visible luminous transmittance and near-infrared blocking capabilities. Nanocomposix has prior experience as both a prime contractor and subcontractor on federal contracts, including work for the Department of...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, for the development of &quot;small hollow nanodelivery vehicles for cancer treatment.&quot; The fixed-price contract has a ceiling value of $200,000.00 and a period of performance ending on March 30, 2010. Nanocomposix has previously performed prime contracts and subcontracts for...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $1,000,000.00 contract is for the development of a product or technology under the SBIR program. As a Phase II award, this indicates the company previously received a Phase I contract for preliminary research and development. The contract has a cost-plus-fixed-fee pricing type and a period of performance through February 24, 2020. Nanocomposix has previously provided lateral flow assay devices, gold nanoparticles, and R&D services for biomedical technologies under contracts with the Department of Health and Human Services and Department of Defense.

Generated 3/23/24, 5:38 AM